Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,060,330
  • Shares Outstanding, K 39,162
  • Annual Sales, $ 1,195 M
  • Annual Income, $ 14,010 K
  • EBIT $ 173 M
  • EBITDA $ 197 M
  • 60-Month Beta 0.71
  • Price/Sales 10.68
  • Price/Cash Flow 124.51
  • Price/Book 10.36

Options Overview Details

View History
  • Implied Volatility 15.31% (+0.28%)
  • Historical Volatility 40.14%
  • IV Percentile 3%
  • IV Rank 4.81%
  • IV High 65.18% on 04/08/25
  • IV Low 12.79% on 01/22/26
  • Expected Move (DTE 22) 6.17 (1.73%)
  • Put/Call Vol Ratio 21.00
  • Today's Volume 44
  • Volume Avg (30-Day) 522
  • Put/Call OI Ratio 0.66
  • Today's Open Interest 3,980
  • Open Int (30-Day) 3,722
  • Expected Range 351.50 to 363.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.12
  • Number of Estimates 8
  • High Estimate 1.24
  • Low Estimate 0.99
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +15.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
290.00 +23.34%
on 01/13/26
362.41 -1.30%
on 01/21/26
+42.81 (+13.60%)
since 12/29/25
3-Month
221.26 +61.67%
on 11/03/25
362.41 -1.30%
on 01/21/26
+124.33 (+53.28%)
since 10/29/25
52-Week
221.26 +61.67%
on 11/03/25
362.41 -1.30%
on 01/21/26
+87.97 (+32.61%)
since 01/29/25

Most Recent Stories

More News
Halper Sadeh LLC Encourages PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm as there may be limited time to enforce your rights.  

RAPT : 57.63 (-0.03%)
LSTA : 4.61 (+0.66%)
PEN : 357.76 (-0.35%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, RAPT, NATH, and LSTA

NEW YORK , Jan. 28, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

NATH : 101.10 (-0.11%)
RAPT : 57.63 (-0.03%)
LSTA : 4.61 (+0.66%)
PEN : 357.76 (-0.35%)
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--PEN, DBRG, FFIC, and EXAS

NEW YORK , Jan. 21, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars...

EXAS : 102.33 (+0.08%)
PEN : 357.76 (-0.35%)
FFIC : 15.56 (+1.24%)
DBRG : 15.41 (+0.20%)
Halper Sadeh LLC Encourages PEN, FONR, GDOT Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm as there may be limited time to enforce your rights.  

GDOT : 12.36 (+1.06%)
PEN : 357.76 (-0.35%)
FONR : 18.64 (-0.11%)
3 Reasons to Sell PEN and 1 Stock to Buy Instead

3 Reasons to Sell PEN and 1 Stock to Buy Instead

PEN : 357.76 (-0.35%)
3 High-Flying Stocks That Fall Short

3 High-Flying Stocks That Fall Short

CGNX : 38.92 (-0.33%)
PEN : 357.76 (-0.35%)
RGEN : 155.54 (-2.82%)
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

NEW YORK and NEW ORLEANS , Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC ("KSF") are investigating...

BSX : 92.41 (-1.47%)
PEN : 357.76 (-0.35%)
Stocks Boosted by Chip Demand Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. March E-mini...

MSTR : 140.22 (-11.51%)
BLK : 1,123.44 (+0.16%)
AMAT : 337.98 (+0.37%)
MPC : 176.94 (+2.87%)
SNDK : 543.91 (+3.09%)
ADI : 316.35 (-0.40%)
MLTX : 16.28 (+0.18%)
$IUXX : 25,753.46 (-1.03%)
COIN : 195.44 (-6.68%)
ASML : 1,447.48 (+1.73%)
ZNH26 : 111-265 (+0.17%)
OXY : 45.66 (+1.85%)
Wall Street steadies as chip stocks bounce back and oil prices ease

Stocks steadied on Wall Street

BLK : 1,123.44 (+0.16%)
KLAC : 1,673.65 (+2.85%)
NVDA : 191.18 (-0.18%)
AMAT : 337.98 (+0.37%)
AVGO : 327.78 (-1.64%)
CVX : 171.85 (+1.13%)
BAC : 52.86 (+2.03%)
$SPX : 6,941.39 (-0.53%)
MS : 181.76 (-0.32%)
BSX : 92.41 (-1.47%)
GS : 934.00 (-0.30%)
$IUXX : 25,753.46 (-1.03%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

NEW YORK , Jan. 15, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions...

PEN : 357.76 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 362.40
2nd Resistance Point 361.72
1st Resistance Point 360.38
Last Price 357.76
1st Support Level 358.36
2nd Support Level 357.68
3rd Support Level 356.34

See More

52-Week High 362.41
Last Price 357.76
Fibonacci 61.8% 308.49
Fibonacci 50% 291.83
Fibonacci 38.2% 275.18
52-Week Low 221.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar